|
⚲
|
| Keyboard |
| Shah Bimal R
✚
|
|
|---|---|
| CIK # | 0001557394 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001557394] | |
| 4 | [0001557394] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Anebulo Pharmaceuticals Inc | |
| Shah Bimal R | |
| Allos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 25,000 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 6,618 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 41,667 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 3,309 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2023-10-06 | Grant | 26,097 | $0.00 |